Thus, we aimed to evaluate the potential role of DNMT3A mutation on poststroke neurological disability in a well‐characterized cohort of AIS patients and to explore the underlying mechanism of DNMT3A‐exacerbated neurological disability in mice with ischemia/reperfusion brain injury. The gene discussed is DNMT3A; the disease is androgen insensitivity syndrome.